Global Women’s Health Market Projected to Reach USD 39.2 Billion by 2024

New York, USA, 2018-Jul-31 — /EPR Network/ —According to the market research report on global women’s health market by Goldstein research, the industry size is anticipated to reach USD 39.2 billion by 2024 from USD 170.0 billion in 2016, flourishing at a CAGR of 3.42% over the forecast period 2016-2024. The major driving factor for women’s health market is improving the healthcare facilities in the countries by substantially increasing the healthcare budgets as a part of social security measures. Based on application, contraceptives hold 31% share of the total women’s health market and is expected to maintain the hegemony over the market in the coming years, owing to the rising awareness of birth control methods.

Women’s health market, based on geography, North America dominated the market with a share of 35.0% in 2016 owing to boosting demand for women’s health products and physiological and emotional issues due to hormonal changes in women over 65 years (15% of female population). North America is closely followed by the Asia Pacific with a CAGR of 3.5% during the forecast period.

Download Exclusive Sample Report: https://www.goldsteinresearch.com/request-sample/global-womens-health-market-analysis-forecast

Market Segmentation

Global Women’s Health Market can be segmented as follows:

By Product Type

• Devices

1. Intra Uterine Devices
2. Vaginal Rings
3. Implants
4. Female Condoms

• Drugs
• Pharmaceutical Pipeline

By Application

• Reproductive Health
• Infertility
• Endometriosis
• Poly Cystic Ovarian Syndrome (PCOS)

1. Contraceptives
2. Method of Contraceptive And Effectiveness
3. Types of Contraceptives

• Post-Menopausal Health

1. Menopause
2. Post-Menopausal Osteoporosis

• Urological Disorders

1. Urinary Incontinence
2. Urinary Tract Infection
3. Others

By Region

• North America
• Europe
• Middle East and Africa
• Latin America
• Asia Pacific

Browse Full Report: https://www.goldsteinresearch.com/report/global-womens-health-market-analysis-forecast

“Women’s Health Market Industry Analysis” contains detailed overview of the global women’s health market. On the basis of our in-depth analysis, market can be segmented in terms of market segmentation by product type and application.

The deep comprehensive analysis of Women’s Health Market Report provides us with some fact & figures which are essential for the market study i.e; industry growth drivers, demand analysis, industry challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Y-O_Y growth rate, key factors, leading business firms, Porter’s five force model etc.

This market research report also includes competitive outlook of some of the major players profiling of companies such as Neurocrine Biosciences, Gedeon Richter Plc, Ferring Pharmaceuticals, Enteris Biopharma, Bayer Healthcare, F. Other industry-leading merchandise are: Bristol-Myers Squibb, EffRx, Ferring International Center, GlaxoSmithKline, HLL Lifecare, Janssen Pharmaceutical, Lipocine, Ligand Pharmaceuticals, Lupin Pharmaceuticals, Amgen, Apothecus Pharmaceutical, Hoffmann-La Roche AG, Pfizer Inc., Plc, Radius Health Inc., Agile Therapeutics,

The company profiles of key players of this particular market include business strategy, geographical revenue distribution, major information of the companies overview, products, services and industries catered, financial analysis, key metrics, revenue, driving factor of the company and latest developments.

Overall, the report represents the global women’s health market trends along with a market forecast that will help industry consultants, technology providers, key opinion leaders to gain a deeper insight of the market existing players searching for expansion opportunities, collaborators, new players, advisors, consultants & other shareholders to align their market strategies.

Browse Similar Report: https://www.goldsteinresearch.com/report/africa-healthcare-market-outlook-opportunity-and-demand-analysis-market-forecast-2016-2024